Jamie Dananberg - Nov 18, 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Medical Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Jamie Dananberg
Stock symbol
UBX
Transactions as of
Nov 18, 2022
Transactions value $
$0
Form type
4
Date filed
11/21/2022, 04:35 PM
Previous filing
Sep 15, 2022
Next filing
Dec 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +65K $0.00 65K Nov 18, 2022 Common Stock 65K $2.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares vest and become exercisable pursuant to the following schedule: One-eighth of the shares subject to the option vest in successive, equal quarterly installments starting on February 18, 2023, subject to the Reporting Person's continued service to Issuer through the applicable vesting date.